Add To Watchlist
Share URL
West Pharmaceutical Services, Inc.
WST: NYSELowest reading is at 26 out of 100. All scores are out of 100.
In Short
About The Company
CEO
Mr. Michel Lagarde
Market Cap
26.07 Billion USD
Sector
Healthcare
Website
https://www.westpharma.comLast Update
28/09/2026, 02:03:13
Description
West Pharmaceutical Services, Inc.
Read More
Strongest readings
- ✔Altman-Z score of 17.28 sits above the distress range
- ✔Financial health is strong (health score 91 out of 100)
- ✔Debt is low at 0.06 times equity
- ✔Return on capital employed of 16.18% is above the market average of 10.00%
- ✔Dividend cover is strong (dividend score 70 out of 100)
Weakest readings
- ✘Price-to-earnings of 47.1 is above the market average of 19.6
- ✘The current price sits above estimated fair value (margin of safety -83.76%)
- ✘Returns on capital have declined over five years (5.20% lower)
- ✘Earnings and cashflow growth is weak (growth score 33 out of 100)
Key Figures
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✘ | Price / earnings (TTM) | 47.13x | 19.60x | |
| ✘ | Margin of safety (DCF) | -83.76% | 17.95% | |
| ✘ | Revenue growth (5y average) | 2.18% | 10.97% | |
| ✘ | Dividend yield (TTM) | 0.24% | 1.85% | |
| ✔ | Share count, per year | -0.44% | 0.00% | |
| ✔ | Return on capital employed | 16.18% | 10.00% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Valuation
26 / 100Priced above the market on most measures.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✘ | Price / earnings | 47.13x | 19.60x | |
| ✘ | Free cashflow yield | 1.40% | 4.70% | |
| ✘ | Price / earnings growth | 39.77x | 1.50x | |
| Price / book | 8.72x | — | ||
| ✘ | Margin of safety | -83.76% | 17.95% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✘Estimated intrinsic value of 60.17 USD is below the current price of 370.44 USD
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Estimated Fair Value: 108.7 USD ✘
Current Price: 370.4 USD
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated fair value for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel for the impact this has on longterm investment returns and find a margin of safety you are comfortable with.
Growth
33 / 100Growing more slowly than the market on most measures.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✘ | Revenue growth | 2.18% | 10.97% | |
| ✘ | Earnings growth | 1.19% | 14.48% | |
| ✘ | Cashflow growth | 10.90% | 12.35% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✔Revenue growth has improved this year (15.69% against a five year average of 2.18%)
- ✔Earnings growth has improved this year (26.77% against a five year average of 1.19%)
- ✔Free cashflow growth has improved this year
Health
91 / 100Balance sheet covers its obligations.
Measured on Leverage and capital, Funding and liquidity, Earnings quality.
| Status | Metric | Value | Reading | Threshold |
|---|---|---|---|---|
| ✔ | Altman-Z score | 17.28 | 3.00 | |
| ✔ | Piotroski score | 7.00 | 5.00 | |
| ✔ | Debt / equity | 0.06x | 0.80x | |
| ✔ | Current ratio | 3.02x | 1.00x | |
| ✔ | Interest coverage | 1169.80x | 2.50x | |
| ✔ | Free cashflow / debt | 2.31x | 0.15x | |
| ✔ | Debt / capital | 0.06x | 1.00x |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Dividend
70 / 100Covered by both earnings and cashflow.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✘ | Dividend yield | 0.24% | 1.85% | |
| ✔ | Dividend growth | 3.55% | 0.00% | |
| ✔ | Payout ratio (earnings) | 10.93% | 40.00% | |
| ✔ | Payout ratio (cashflow) | 16.96% | 65.00% | |
| ✔ | Worst year, last 5 years | 4.56% | -2.00% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✘Dividend growth has been slowing recently
Management
57 / 100Returns on capital are at or above the market.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✔ | Return on equity | 15.54% | 15.00% | |
| ✔ | Return on capital employed | 16.18% | 10.00% | |
| Return on assets | 11.56% | — | ||
| Free cashflow return on capital | 12.97% | — | ||
| ✘ | Return on capital, 5y change | -5.20% | 0.00% | |
| ✔ | Share count, per year | -0.44% | 0.00% | |
| ✔ | Share count, recent | -2.66% | 0.00% | |
| ✘ | Realized buyback return | -51.03% | 0.00% | |
| ✔ | Goodwill erosion / equity | 0.20% | 2.00% | |
| Price volatility, 5 year | 41.54% | — |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✘Shares were repurchased while the value score was only 26 out of 100
Analysts
not enough data| Status | Metric | Value | Reading | Neutral |
|---|---|---|---|---|
| Analyst opinion score | N/A | 50 |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Financial History
Annual figures across the full reporting history we hold.
Market Peers
WST
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
See 35+ Years Annual ReportsOther Information
Company Name
West Pharmaceutical Services, Inc.
Currency
USD
Beta
1.135
Vol Avg
655342
Ceo
Mr. Michel Lagarde
Cik
0000105770
Cusip
Exchange
NYSE
Full Time Employees
10800
Industry
Medical Instruments & Supplies
Sector
Healthcare
Ipo Date
Address
530 Herman O. West Drive
City
Exton
State
PA
Country
United States
Zip
19341-1147
Phone
610 594 2900
Analysis Last Updated
28/09/2026, 02:03:13
Financial data compiled from SEC EDGAR filings and Yahoo Finance.